Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
Spencer TJ, Kratochvil CJ, Sangal RB, Saylor KE, Bailey CE, Dunn DW, Geller DA, Casat CD, Lipetz RS, Jain R, Newcorn JH, Ruff DD, Feldman PD, Furr AJ, Allen AJ. Spencer TJ, et al. Among authors: allen aj. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):689-700. doi: 10.1089/cap.2006.0100. J Child Adolesc Psychopharmacol. 2007. PMID: 17979588
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses.
Kratochvil CJ, Michelson D, Newcorn JH, Weiss MD, Busner J, Moore RJ, Ruff DD, Ramsey J, Dickson R, Turgay A, Saylor KE, Luber S, Vaughan B, Allen AJ; ATOMOXETINE HIGH-DOSE STUDY GROUP. Kratochvil CJ, et al. Among authors: allen aj. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1128-1137. doi: 10.1097/chi.0b013e318074eeb3. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17712236 Clinical Trial.
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
Atomoxetine ADHD and Comorbid MDD Study Group; Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ, Busner J, Duesenberg DA, Harshawat P, Kaplan SL, Quintana H, Allen AJ, Sumner CR. Atomoxetine ADHD and Comorbid MDD Study Group, et al. Among authors: allen aj. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):407-20. doi: 10.1089/cap.2007.0066. J Child Adolesc Psychopharmacol. 2007. PMID: 17822337 Clinical Trial.
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
Spencer TJ, Sallee FR, Gilbert DL, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Milton DR, Feldman PD, Kelsey DK, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M. Spencer TJ, et al. Among authors: allen aj. J Atten Disord. 2008 Jan;11(4):470-81. doi: 10.1177/1087054707306109. Epub 2007 Oct 12. J Atten Disord. 2008. PMID: 17934184 Clinical Trial.
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D; Atomoxetine/Methylphenidate Comparative Study Group. Newcorn JH, et al. Among authors: allen aj. Am J Psychiatry. 2008 Jun;165(6):721-30. doi: 10.1176/appi.ajp.2007.05091676. Epub 2008 Feb 15. Am J Psychiatry. 2008. PMID: 18281409 Clinical Trial.
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D. Michelson D, et al. Among authors: allen aj. Am J Psychiatry. 2002 Nov;159(11):1896-901. doi: 10.1176/appi.ajp.159.11.1896. Am J Psychiatry. 2002. PMID: 12411225 Clinical Trial.
237 results